[Aortic inflammatory lesions in Behçet's disease]

Rev Med Interne. 2016 Apr;37(4):230-8. doi: 10.1016/j.revmed.2015.10.351. Epub 2015 Nov 21.
[Article in French]

Abstract

The arterial lesions affect about 10% of patients with Behçet's disease (BD). Aortic inflammatory involvement includes predominantly aortic aneurysmal lesions affecting most often the abdominal aorta. They account for the severity of the disease and are a leading cause of death when they hit the aorta or pulmonary arteries. Within the arterial lesions of BD, aortic involvement is, with femoral lesions, the most common site involved (18-28% of patients with vascular disease). Unlike other large vessels vasculitis (i.e. giant cell arteritis and Takayasu's arteritis) diffuse aortitis is observed in less than 5% of patients with BD. Aortic lesions of BD may be asymptomatic (systematic imaging or occasionally associated with other vascular event) or be revealed by the occurrence of abdominal, thoracic or lumbar pain, or an aortic valve insufficiency. Fever is frequently associated. Increase in acute phase reactants is common in these patients. Histological analysis may show infiltration by lymphocytes, neutrophils and plasma cells in the media and adventitia and a proliferation of the vasa vasorum in the media as well as a fibroblastic proliferation. In the later phase, a fibrous thickening of the media and adventitia is observed as well as a proliferation and thickening of the vasa vasorum. The therapeutic management should always include a medical treatment for the control of inflammation (corticosteroids, immunosuppressive drugs and/or biotherapy) and often an endovascular or surgical treatment if the aneurysm is threatening. The choice between endovascular or surgical treatment is considered case by case, depending on the experience of the team, anatomical conditions and of the clinical presentation. In this review, we provide a detailed and updated review of the literature to describe the aortic inflammatory damage associated with Behçet's disease.

Keywords: Angio-Behçet; Anévrysme aortique; Aortic aneurysm; Aortite; Aortitis; Behcet's disease; Biotherapy; Biothérapie; Immunosuppresseurs; Immunosuppressive drugs; Maladie de Behçet; Vascularite; Vasculitis.

Publication types

  • Review

MeSH terms

  • Aortic Aneurysm / diagnostic imaging
  • Aortic Aneurysm / etiology
  • Aortic Aneurysm / therapy
  • Aortitis / complications*
  • Aortitis / diagnostic imaging
  • Aortitis / therapy
  • Behcet Syndrome / complications*
  • Behcet Syndrome / diagnostic imaging
  • Behcet Syndrome / therapy
  • Biological Therapy / methods
  • Giant Cell Arteritis / diagnostic imaging
  • Giant Cell Arteritis / etiology
  • Giant Cell Arteritis / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Takayasu Arteritis / diagnostic imaging
  • Takayasu Arteritis / etiology
  • Takayasu Arteritis / therapy

Substances

  • Immunosuppressive Agents